"The FDA won't care that CYP stuffed up MEND. They'll care about the trial designs of the trials that relate to their own approvals and be too busy for silliness that doesn't."
1. Your position in the FDA is? Yes, that's right!
2. They aren't St. Vincent De Paul. They aren't about to waste their time. You are saying (from your position of authority within the FDA - refer 1. above) that capability of applicants isn't taken into account? Are you sure about that?
3. You're a walking, talking, typing design flaw.
All CYP shareholders are FDA experts. Funny as!
Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-185
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |